Havana, Cuba

Elizabeth Blanco Garcés

This inventor holds 1 USPTO granted patent. Top assignee: Centro De Ingenieria Genetica Y Biotecnologia. Active years: 2008.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Elizabeth Blanco Garcés. Retrieved from https://idiyas.com/inventor/elizabeth-blanco-garcés

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 5.0

ph-index = 1

Forward Citations = 1(Granted Patents)


Company Filing History:


Years Active: 2008

Loading Chart...
1 patent (USPTO):Explore Patents

Title: The Innovative Contributions of Elizabeth Blanco Garcés

Introduction

Elizabeth Blanco Garcés is a prominent inventor based in La Habana, Cuba. She has made significant strides in the field of biotechnology, particularly in the development of therapeutic proteins. Her work has the potential to impact various medical conditions, showcasing her dedication to advancing healthcare solutions.

Latest Patents

Elizabeth holds a patent for a groundbreaking invention titled "Chimeric antagonist anth1." This recombinant chimeric antagonist is formed by a 60 amino acid fragment of the N-terminal region of human interleukin 2 (IL-2) fused to the N-terminal of the extracellular region of the alpha subunit of the gamma IFN (IFN γ) receptor. In vitro studies have demonstrated that this protein possesses T cell growth-stimulating activity while inhibiting the growth-stimulating effects of IL-2 in T cells. Additionally, it inhibits the induction of HLA-DR by IFN γ and the antiproliferative activity of γ IFN. This invention holds promise for treating various pathologies, including autoimmune diseases, graft rejections, chronic inflammations, sepsis, ischemia and reperfusion syndrome, and atherosclerosis.

Career Highlights

Elizabeth is affiliated with the Centro de Ingeniería Genética y Biotecnología, where she continues to contribute to innovative research and development in genetic engineering and biotechnology. Her work is characterized by a commitment to addressing complex medical challenges through scientific innovation.

Collaborations

Throughout her career, Elizabeth has collaborated with notable colleagues, including Iraldo Bello Rivero and Yeny Torres Ruiz. These partnerships have fostered a collaborative environment that enhances the potential for groundbreaking discoveries in their field.

Conclusion

Elizabeth Blanco Garcés exemplifies the spirit of innovation in biotechnology through her patented work and collaborative efforts. Her contributions are paving the way for advancements in medical treatments, reflecting her commitment to improving health outcomes.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…